NCT05674370 is a NA clinical trial of GRIP Electronic Diagnostic Chip in COVID-19, sponsored by Mayo Clinic.

Who is sponsoring NCT05674370?

NCT05674370 is sponsored by Mayo Clinic.

What drugs are being tested in NCT05674370?

Interventions in NCT05674370: GRIP Electronic Diagnostic Chip, Laboratory-based nucleic acid amplification tests (NAATs).

What condition does NCT05674370 study?

NCT05674370 studies COVID-19, Influenza.

Is NCT05674370 still recruiting?

NCT05674370 is currently completed. Last updated 21 March 2024.

Are results published for NCT05674370?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2024-03-21 · How we verify

NCT05674370

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Study of the GRIP Influenza and SARS-CoV-2 POC Assays

Completed NA Results posted Last updated 21 March 2024

What this trial tests

NA trial testing GRIP Electronic Diagnostic Chip in COVID-19 in 45 participants. Completed in 30 April 2023.

Timeline

1 February 2023

Primary endpoint
30 April 2023

30 April 2023

Quick facts

Lead sponsor	Mayo Clinic
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	45
Start date	1 February 2023
Primary completion	30 April 2023
Estimated completion	30 April 2023
Sites	1 location across United States

Drugs / interventions tested

GRIP Electronic Diagnostic Chip
Laboratory-based nucleic acid amplification tests (NAATs)

Conditions studied

COVID-19 — all drugs for COVID-19 →
Influenza — all drugs for Influenza →

Sponsor

Mayo Clinic

Who can join

18 and older, any sex, with COVID-19 or Influenza. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Positive Percent Agreement Primary · One hour

Percent of nasal swabs to report positive results for respiratory virus for both the GRIP device and NAAT routine clinical testing

Group	Value	95% CI
Novel, Graphene-based, Point-of-care Device	52

Negative Percent Agreement Primary · One hour

Percent of nasal swabs to report negative results for respiratory virus for both the GRIP device and NAAT routine clinical testing

Group	Value	95% CI
Novel, Graphene-based, Point-of-care Device	44

Sponsor's own description

The purpose of this research is to determine if the use of a new device can accurately detect a virus infection.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for COVID-19

Currently open trials in the same condition.

NCT07183709 — Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults · Phase 1 · active not recruiting
NCT07300839 — A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age · Phase 3 · active not recruiting
NCT07221162 — A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes · Phase 1 · recruiting
NCT07215520 — Safety and Tolerability of a Newcastle Disease Virus-Based Mucosal COVID-19 Vaccine in Previously Vaccinated Adults · Phase 2 · recruiting
NCT07222384 — A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That A · Phase 3 · active not recruiting

Other Mayo Clinic trials

Trials by the same sponsor.

NCT07126548 — A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men · NA · not yet recruiting
NCT07221656 — Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration · not yet recruiting
NCT06891001 — The Utilization of a Shoe Insert on Individuals With Unilateral Greater Trochanteric Pain Syndrome on Single Leg Stance, · NA · not yet recruiting
NCT07169799 — Impact of Cryotherapy Spray (Tru-Freeze) for the Eradication of Gastric Antral Vascular Ectasia (ICE-GAVE) · NA · recruiting
NCT07086183 — Perioperative Risk in Patients on Chronic Aspirin Undergoing Craniotomy · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05674370 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mayo Clinic
Last refreshed: 21 March 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05674370.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing